PHAT stock news
This page provides real-time market news, earnings updates, and company announcements related to Phathom Pharmaceuticals, Inc. (PHAT).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-28 08:10 EST
13F report shows: Carlyle Group established long positions in Medline, popular broker Robinhood, and Spyre Therapeutics in Q4
华尔街见闻2026-02-13 22:13:44
Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX)
Finviz2026-02-16 17:24:48
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Finviz2026-02-23 13:03:47
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Finviz2026-02-23 13:03:47
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Finviz2026-02-26 12:03:46
Phathom's Fourth Quarter Outperformance: Did the Market Anticipate the Growth?
101 finance2026-02-26 12:36:52
Phathom Pharmaceuticals, Inc. (PHAT) Posts Fourth Quarter Loss, Surpasses Revenue Projections
101 finance2026-02-26 18:18:49
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Finviz2026-02-26 12:03:46
Phathom's Fourth Quarter Outperformance: Did the Market Anticipate the Growth?
101 finance2026-02-26 12:36:52
Phathom Pharmaceuticals, Inc. (PHAT) Posts Fourth Quarter Loss, Surpasses Revenue Projections
101 finance2026-02-26 18:18:49
PHAT stock chart
PHAT stock detailsPHAT stock price change
On the last trading day, PHAT stock closed at 12.75 USD, with a price change of -5.97% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more